3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neuroendocrine Tumors
4
Meningioma
2
Glioblastoma
2
Sarcoma, Synovial
1
Recurrence
1
Prostatic Neoplasms
1
Pheochromocytoma
1
Paraganglioma
1
Osteosarcoma
1
Neuroblastoma
1
Metastatic Digestive System Neuroendocrine Tumor G1
1
Medulloblastoma
1
Glioma
1
Extensive Stage Small Cell Lung Cancer
1
Esthesioneuroblastoma, Olfactory
1
Ependymoma
1
Disease Progression
1
Carcinoid Tumor
1
Breast Neoplasms
1
Adrenal Gland Neoplasms
1
Adrenal Cortex Neoplasms
1
Interventions
pembrolizumab
1
fludarabine phosphate
1
fludarabine
1
decitabine and cedazuridine drug combination
1
avelumab
1
aldesleukin
1
Nivolumab
1
Cyclophosphamide
1
Axitinib
1
Antineoplastic Protocols
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Merkel Cell
×
lutetium Lu 177 dotatate
×
30 days
×
Clear all
No trials found.